drugset / Trial / NCT05165199

Elobixibat for Chronic Constipation Without Defecation Desire

NCT05165199

Phase 4 Unknown 40 enrolled Yokohama City University
NaSingle-groupOpen-labelTreatment

Summary

Patients of chronic constipation without defecation desire will be orally administered elobixibat 10 mg once daily before meals for 4 weeks. The primary endpoint of the pre/post comparative study will be the percentage of improvement in bowel movements from Week 2 of the observation period at Week 4 of the treatment period.

Timeline

Start
2022-03-01
Primary completion
2022-09
Completion
2023-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Elobixibat Small molecule 10 mg Oral

Indications